Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:595

Official publication of the Indian Society of Nephrology
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients

Ghorbani A, Aalamshah M, Shahbazian H, Ehsanpour A, Aref A

Year : 2009| Volume: 19| Issue : 2 | Page no: 57-61

   This article has been cited by
 
1 Antiplatelet agents for chronic kidney disease
Patrizia Natale, Suetonia C Palmer, Valeria M Saglimbene, Marinella Ruospo, Mona Razavian, Jonathan C Craig, Meg J Jardine, Angela C Webster, Giovanni FM Strippoli
Cochrane Database of Systematic Reviews. 2022; 2022(2)
[Pubmed]  [Google Scholar] [DOI]
2 Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience
Sunnesh Reddy Anapalli, Harini Devi N., Pvgk Sarma, Lokanathan Srikanth, Siva Kumar V.
Renal Failure. 2022; 44(1): 34
[Pubmed]  [Google Scholar] [DOI]
3 Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
Imran Mohamed, Mohamad Fathul Aizat Kamarizan, Antonio Da Silva
Cochrane Database of Systematic Reviews. 2021; 2021(7)
[Pubmed]  [Google Scholar] [DOI]
4 KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Charmaine E. Lok, Thomas S. Huber, Timmy Lee, Surendra Shenoy, Alexander S. Yevzlin, Kenneth Abreo, Michael Allon, Arif Asif, Brad C. Astor, Marc H. Glickman, Janet Graham, Louise M. Moist, Dheeraj K. Rajan, Cynthia Roberts, Tushar J. Vachharajani, Rudolph P. Valentini
American Journal of Kidney Diseases. 2020; 75(4): S1
[Pubmed]  [Google Scholar] [DOI]
5 A multicentre analysis of the outcome of arteriovenous fistula in maintenance haemodialysis
Swathi Jothi, Hareesh KG, Nancy Lesley, Madhusudan Vijayan, Sneha Haridas Anupama, Milly Mathew, Rajeevalochana Parthasarathy, Saravanan Sundarajan, Nagarajan P, Latha Kumaraswamy, Georgi Abraham
Seminars in Dialysis. 2020; 33(5): 388
[Pubmed]  [Google Scholar] [DOI]
6 Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula
Te-I. Chang, Cheng-Hsien Chen, Hui-Ling Hsieh, Chun-You Chen, Shih-Chang Hsu, Ho-Shun Cheng, Wen-Cheng Huang, Yuh-Mou Sue, Yung-Ho Hsu, Feng-Yen Lin, Chun-Ming Shih, Shing-Jong Lin, Po-Hsun Huang, Chung-Te Liu
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
7 Clopidogrel Use in End-Stage Kidney Disease
Bassem Y. Tanios,Houssam S. Itani,Deborah L. Zimmerman
Seminars in Dialysis. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
8 Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis
Suetonia C. Palmer,Lucia Di Micco,Mona Razavian,Jonathan C. Craig,Pietro Ravani,Vlado Perkovic,Gianni Tognoni,Giusi Graziano,Meg Jardine,Fabio Pellegrini,Antonio Nicolucci,Angela Webster,Giovanni F.M. Strippoli
American Journal of Kidney Diseases. 2013; 61(1): 112
[Pubmed]  [Google Scholar] [DOI]
9 Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis
Palmer, S.C. and Di Micco, L. and Razavian, M. and Craig, J.C. and Ravani, P. and Perkovic, V. and Tognoni, G. and Graziano, G. and Jardine, M. and Pellegrini, F. and Nicolucci, A. and Webster, A. and Strippoli, G.F.M.
American Journal of Kidney Diseases. 2013; 61(1): 112-122
[Pubmed]  [Google Scholar]
10 Patients on hemodialysis are better served by a proximal arteriovenous fistula for long-term venous access
Sultan, S. and Hynes, N. and Hamada, N. and Tawfick, W.
Vascular and Endovascular Surgery. 2012; 46(8): 624-634
[Pubmed]  [Google Scholar]
11 Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease:A systematic review and meta-analysis
Palmer, S.C., Micco, L.D., Razavian, M., Craig, J.C., Perkovic, V., Pellegrini, F., Copetti, M., (...), Strippoli, G.F.M.
Annals of Internal Medicine. 2012; 156(6): 445-459
[Pubmed]  [Google Scholar]
12 Effect of antiplatelet agents, statins, and other drugs on vascular access patency rates
Paraskevas, K.I., Mikhailidis, D.P., Roussas, N., Giannoukas, A.D.
Angiology. 2012; 63(1): 5-8
[Pubmed]  [Google Scholar]
13 Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement
Rubie Sue Jackson, Anton N. Sidawy, Richard L. Amdur, Akhil Khetarpal, Robyn A. Macsata
Journal of Vascular Surgery. 2011;
[HTML Full text]  [Google Scholar] [DOI]

 

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07